These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 28294905)

  • 1. [Evaluation of the Antianginal Efficacy of Ivabradine In Patients With Ischemic Heart Disease Complicated by Heart Failure].
    Lopatin On Behalf Of The Participants Of The Russian Multicenter Observational Program Nachalo YM
    Kardiologiia; 2015 May; 55(5):5-11. PubMed ID: 28294905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the Antianginal Efficacy of Ivabradine In Patients With Ischemic Heart Disease Complicated by Heart Failure].
    Lopatin YM;
    Kardiologiia; 2015; 55(5):5-11. PubMed ID: 26615618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [LINKOR: results of observational program in patients with myocardial infarction].
    Glezer MG
    Kardiologiia; 2013; 53(5):74-82. PubMed ID: 23952999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ivabradine in combination with beta-blocker reduces symptoms and improves quality of life in elderly patients with stable angina pectoris: age-related results from the ADDITIONS study.
    Müller-Werdan U; Stöckl G; Ebelt H; Nuding S; Höpfner F; Werdan K;
    Exp Gerontol; 2014 Nov; 59():34-41. PubMed ID: 25193811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the antianginal effectiveness of trimetazidine in a new dosage form for a single dose, depending on the region of the Russian Federation. ODA trial results].
    Glezer MG; Vygodin VA
    Kardiologiia; 2019 Sep; 59(10S):52-63. PubMed ID: 31876462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of stable angina pectoris by ivabradine in every day practice: the REDUCTION study.
    Köster R; Kaehler J; Meinertz T;
    Am Heart J; 2009 Oct; 158(4):e51-7. PubMed ID: 19781403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the I(f) inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) study.
    Fox K; Ferrari R; Tendera M; Steg PG; Ford I;
    Am Heart J; 2006 Nov; 152(5):860-6. PubMed ID: 17070146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of I(f) inhibition with ivabradine in different subpopulations with stable angina pectoris.
    Tendera M; Borer JS; Tardif JC
    Cardiology; 2009; 114(2):116-25. PubMed ID: 19468225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term safety and efficacy of ivabradine in patients with chronic stable angina.
    López-Bescós L; Filipova S; Martos R
    Cardiology; 2007; 108(4):387-96. PubMed ID: 17890862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ivabradine in patients with stable angina receiving β-blockers according to baseline heart rate: an analysis of the ASSOCIATE study.
    Tardif JC; Ponikowski P; Kahan T;
    Int J Cardiol; 2013 Sep; 168(2):789-94. PubMed ID: 23138014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of ivabradine in combination with Beta-blocker versus uptitration of Beta-blocker in patients with stable angina.
    Amosova E; Andrejev E; Zaderey I; Rudenko U; Ceconi C; Ferrari R
    Cardiovasc Drugs Ther; 2011 Dec; 25(6):531-7. PubMed ID: 21830063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of ivabradine in patients with coronary artery disease and left ventricular systolic dysfunction (from the BEAUTIFUL Holter Substudy).
    Tendera M; Talajic M; Robertson M; Tardif JC; Ferrari R; Ford I; Steg PG; Fox K;
    Am J Cardiol; 2011 Mar; 107(6):805-11. PubMed ID: 21247517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
    Szwed H; Pachocki R; Domzal-Bochenska M; Szymczak K; Szydlowski Z; Paradowski A; Gajos G; Kaluza G; Kulon I; Wator-Brzezińska A; Elikowski W; Kuźniak M
    Presse Med; 2000 Mar; 29(10):533-8. PubMed ID: 10761517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Ivabradine on Central Aortic Blood Pressure and Myocardial Perfusion in Patients With Stable Coronary Artery Disease.
    Dillinger JG; Maher V; Vitale C; Henry P; Logeart D; Manzo Silberman S; Allée G; Levy BI
    Hypertension; 2015 Dec; 66(6):1138-44. PubMed ID: 26418022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivabradine in Combination with Metoprolol Improves Symptoms and Quality of Life in Patients with Stable Angina Pectoris: A post hoc Analysis from the ADDITIONS Trial.
    Werdan K; Ebelt H; Nuding S; Höpfner F; Stöckl G; Müller-Werdan U;
    Cardiology; 2016; 133(2):83-90. PubMed ID: 26501486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy.
    Belardinelli R
    Rev Port Cardiol; 2000 Nov; 19 Suppl 5():V35-9. PubMed ID: 11206102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ivabradine: recent and potential applications in clinical practice.
    Riccioni G
    Expert Opin Pharmacother; 2011 Feb; 12(3):443-50. PubMed ID: 21254949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.
    Canet E; Lerebours G; Vilaine JP
    Ann N Y Acad Sci; 2011 Mar; 1222():90-9. PubMed ID: 21434947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus.
    Borer JS; Tardif JC
    Am J Cardiol; 2010 Jan; 105(1):29-35. PubMed ID: 20102886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.